M1 muscarinic agonists as a therapeutic strategy in Alzheimer's disease - M1 muscarinic agonists in Alzheimer's disease

被引：0
作者：
Fisher, A
Pittel, Z
Haring, R
Brandeis, R
Bar-Ner, N
Sonego, H
Marcovitch, I
Natan, N
Mestre-Frances, N
Bons, N
机构：
[1] Israel Inst Biol Res, IL-74100 Ness Ziona, Israel
[2] Univ Montpellier 2, Montpellier, France
来源：
MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
引用
收藏
页码：205 / 210
页数：6
相关论文
共 27 条
  • [1] Cholinergic deafferentation of the rabbit cortex:: a new animal model of Aβ deposition
    Beach, TG
    Potter, PE
    Kuo, YM
    Emmerling, MR
    Durham, RA
    Webster, SD
    Walker, DG
    Sue, LI
    Scott, S
    Layne, KJ
    Roher, AE
    [J]. NEUROSCIENCE LETTERS, 2000, 283 (01) : 9 - 12
  • [2] Reduction of cerebrospinal fluid amyloid β after systemic administration of M1 muscarinic agonists
    Beach, TG
    Walker, DG
    Potter, PE
    Sue, LI
    Fisher, A
    [J]. BRAIN RESEARCH, 2001, 905 (1-2) : 220 - 223
  • [3] Bons N., 1995, ALZHEIMERS RES, V1, P83
  • [4] DEMENTIA - THE NEUROCHEMICAL BASIS OF PUTATIVE TRANSMITTER ORIENTATED THERAPY
    COURT, JA
    PERRY, EK
    [J]. PHARMACOLOGY & THERAPEUTICS, 1991, 52 (03) : 423 - 443
  • [5] Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists
    Fisher, A
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 2000, 84 (02) : 101 - 112
  • [6] Muscarinic receptor agonists in Alzheimer's disease - More than just symptomatic treatment?
    Fisher, A
    [J]. CNS DRUGS, 1999, 12 (03) : 197 - 214
  • [7] Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3β inhibition and in neurons
    Forlenza, OV
    Spink, JM
    Dayanandan, R
    Anderton, BH
    Olesen, OF
    Lovestone, S
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (10) : 1201 - 1212
  • [8] Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment
    Genis, I
    Fisher, A
    Michaelson, DM
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 72 (01) : 206 - 213
  • [9] Quantitative analysis of tau protein-immunoreactive accumulations and beta amyloid protein deposits in the cerebral cortex of the mouse lemur, Microcebus murinus
    Giannakopoulos, P
    Silhol, S
    Jallageas, V
    Mallet, J
    Bons, N
    Bouras, C
    Delaere, P
    [J]. ACTA NEUROPATHOLOGICA, 1997, 94 (02) : 131 - 139
  • [10] Increased levels of tau protein in SH-SY5Y cells after treatment with cholinesterase inhibitors and nicotinic agonists
    Hellström-Lindahl, E
    Moore, H
    Nordberg, Y
    [J]. JOURNAL OF NEUROCHEMISTRY, 2000, 74 (02) : 777 - 784
123